Evolent Health Inc (EVH) financials · $474.7M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Evolent Health Inc (EVH) $474.7M cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Revenue | $652.5M | $496.2M |
| Cost of Revenue | $571.7M | $412.5M |
| Gross Profit | $80.8M | $83.8M |
| Operating Income | -$9.56M | -$10.6M |
| Net Income | -$28.4M | -$26.6M |
| EPS (Diluted) | -$0.25 | -$0.24 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $1.97B | $1.88B |
| Current Assets | $610.5M | $502.0M |
| Cash & Equivalents | $115.7M | $142.0M |
| PP&E | $81.9M | $81.2M |
| Total Liabilities | $1.59B | $1.48B |
| Current Liabilities | $492.8M | $381.2M |
| Long-term Debt | $966.5M | $973.5M |
| Total Debt | $966.5M† | $973.5M† |
| Shareholders' Equity | $383.2M | $396.4M |
| Retained Earnings | -$1.37B | -$1.34B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $38.8M | $18.8M |
| Investing Cash Flow | -$233.0K | -$62.9M |
| Financing Cash Flow | -$35.9M | -$565.0K |
| Net Change in Cash | $2.20M | -$45.0M |
FAQ
What is EVH P/E and revenue?
Evolent Health Inc (EVH) $474.7M cap.
What is EVH revenue?
Evolent Health Inc last cached revenue is $652.5M (Q2 2026).
Is EVH profitable?
Evolent Health Inc last cached net income is -$28.4M (Q2 2026).
What are EVH total assets?
Evolent Health Inc last cached total assets are $1.97B (Q2 2026).
What is EVH free cash flow?
No cached cash-flow row for EVH yet.
Not investment advice. Cached statements, not a live tape.